comparemela.com

Latest Breaking News On - Spondyloarthritis international society - Page 8 : comparemela.com

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions - read this article along with other careers information, tips and advice on BioSpace

Ji xingUnited statesNew zealandUnited kingdomBritish columbiaSan diegoMetrion biosciencesErik gatenholmSelective inhibitor of nuclear exportEngland avacta groupDrug administrationJi xing pharmaceuticalsCanadian ministry of innovationAssessment of spondyloarthritis international societyBioqube factory fundTechnology oganisation

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

Ji xingUnited statesNew zealandUnited kingdomBritish columbiaSan diegoMetrion biosciencesErik gatenholmSelective inhibitor of nuclear exportEngland avacta groupDrug administrationJi xing pharmaceuticalsCanadian ministry of innovationAssessment of spondyloarthritis international societyBioqube factory fundTechnology oganisation

Significant Improvements Seen With Bimekizumab in Ankylosing Spondylitis Trial

The ongoing phase 3 BE MOBILE 2 study compared the efficacy and safety of bimekizumab to placebo in 332 adults with active ankylosing spondylitis.

Emmanuel caeymaexImmunology solutionsDrug administrationAssessment of spondyloarthritis international societySpondyloarthritis international societyAnkylosing spondylitis disease activity scoreExecutive vice presidentBiologics license application

Positive Top-Line Results for Bimekizumab in Phase 3 Ankylosing Spondylitis Trial

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomBruxelles capitaleNicole hergaEmmanuel caeymaexMusculoskelet disordEimear obrienAntje witteJ clin pharmacolImmunology solutionsBrand communicationsDrug administrationAssessment of spondyloarthritis international societyCorporate communicationsSource ucb incSpondyloarthritis international society

Tofacitinib Approved for New Ankylosing Spondylitis Indication

The action makes the drug the first Janus kinase (JAK) inhibitor to be approved for ankylosing spondylitis.

Assessment in spondyloarthritis international societyDrug administrationSpondyloarthritis international societyAnkylosing spondylitisAnkylosing spondylitis bechterews diseaseRheumatoid arthritisUlcerative colitisPsoriatic arthritisAnti tnfAnti tumor necrosis factorBiologic therapyUs food and drug administrationNited states food and drug administrationSocial issuesMyocardial infarctionAlignant neoplasia

vimarsana © 2020. All Rights Reserved.